Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Ilex MedicalXTAE:ILX -1.80%63 Days Payable is 68.16 as of Mar. 2026, which is 15% below its 10-year median of 80.07. GuruFocus rates XTAE:ILX with a GF Score™ of 63/100 and a GF Value™ of ₪63.52 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 794 Medical Devices & Instruments companies, Ilex Medical ranks worse than 56.42% on this metric.
The historical rank and industry rank for Ilex Medical's Days Payable or its related term are showing as below:
XTAE:ILX'
s Days Payable Range Over the Past 10 Years
Min: 61.89 Med: 80.07 Max: 86.34
Current: 61.89
During the past 13 years, Ilex Medical's highest Days Payable was 86.34. The lowest was 61.89. And the median was 80.07.
XTAE:ILX's Days Payable is ranked worse than 56.42% of 794
companies
in the Medical Devices & Instruments industry
Industry Median: 67.97
vs XTAE:ILX: 61.89
Ilex Medical's Days Payable
increased
from Mar. 2025 (60.32) to Mar. 2026 (68.16).
It may suggest that Ilex Medicaldelayed paying its suppliers.
Ilex Medical Days Payable Related Terms
Ilex Medical Days Payable Historical Data
* Premium members only.
The historical data trend for Ilex Medical's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XTAE:ILX vs ABT, SYK, MDT: Days Payable Comparison
For the Medical Devices subindustry, Ilex Medical's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ilex Medical Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Ilex Medical's Days Payable distribution charts can be found below:
* The bar in red indicates where Ilex Medical's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Ilex Medical's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ilex Medical (XTAE:ILX) has a Days Payable of 68.16 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Ilex Medical and its competitors. This is 15% below median its historical median of 80.07. Over the past decade, Ilex Medical's Days Payable has ranged from 61.89 to 86.34. According to the industry distribution chart, Ilex Medical ranks #448 out of 794 companies in the Medical Devices & Instruments industry, placing it in the top 56.4%.
Is Ilex Medical's Days Payable too high?
Ilex Medical's current Days Payable of 68.16 is 15% below median its 10-year median of 80.07. Over the past 10 years, this metric has ranged from a low of 61.89 to a high of 86.34. The Medical Devices & Instruments industry median Days Payable is 67.97. Ilex Medical's value of 68.16 is 0.3% above this industry median. Based on the distribution chart, Ilex Medical ranks #448 out of 794 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Ilex Medical has a GF Score™ of 63/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Ilex Medical's Days Payable compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Ilex Medical ranks #448 out of 794 companies for Days Payable. This places Ilex Medical in the lower half of its industry. The industry median Days Payable is 67.97. Ilex Medical's value of 68.16 is 0.3% above this benchmark. Historically, Ilex Medical's own Days Payable has ranged from 61.89 to 86.34 over the past decade. While the company's 10-year median is 80.07 vs. the industry median of 67.97, Ilex Medical has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 67.97, based on 794 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ilex Medical's current Days Payable of 68.16 is 0.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Ilex Medical and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 67.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ilex Medical's current Days Payable is 68.16, which is 15% below median its own 10-year median of 80.07. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ilex Medical stock overvalued right now?
Based on GuruFocus' analysis, Ilex Medical (XTAE:ILX) is currently considered Modestly Undervalued. The stock's GF Value™ is ₪63.52, compared to a current price of ₪48.50 — trading 23.6% below its estimated fair value. The current Days Payable is 68.16, which is 15% below median its 10-year median of 80.07 and 0.3% above the Medical Devices & Instruments industry median of 67.97. Ilex Medical's overall GF Score™ is 63/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Ilex Medical (XTAE:ILX), the current Days Payable is 68.16 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ilex Medical (XTAE:ILX) Overvalued in 2026?
Based on GuruFocus' analysis, Ilex Medical stock appears to be undervalued.
The current stock price of ₪48.50 is trading 23.6% below its estimated GF Value™ of ₪63.52.
GuruFocus considers Ilex Medical to be Modestly Undervalued.
Key valuation signals for XTAE:ILX:
Days Payable: 68.16 (15% below median its 10-year median of 80.07)
GF Value™: ₪63.52 vs. price of ₪48.50 (23.6% below fair value)
Industry Position: 0.3% above the Medical Devices & Instruments median (#448 of 794)
No single metric tells the full story. See the XTAE:ILX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ilex Medical Ltd is an Israel based company engages in the marketing and distribution of diagnostic products and other medical laboratory information systems. It offers in-vitro diagnostic equipment, reagents, laboratory management software, blood bank diagnostic kits, and diagnostic support services to the healthcare sector in Israel.
63GF Score
Get the complete analysis for XTAE:ILX
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XTAE:ILX has been successfully added to your 
